Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Hazra Website

Rohan Hazra, M.D.

Selected Publications

1)  Havens PL, Hazra R, Stephensen CB, Kiser JJ, Flynn PM, Wilson CM, Rutledge B, Bethel J, Pan CG, Woodhouse LR, Van Loan MD, Liu N, Lujan-Zilbermann J, Baker A, Kapogiannis BG, Gordon CM, Mulligan K.
Vitamin D3 supplementation increases fibroblast growth factor-23 in HIV-infected youth treated with tenofovir disoproxil fumarate.
Antivir. Ther. (Lond.). 2014.
2)  Hazra R, Hance LF, Monteiro JP, Ruz NP, Machado DM, Saavedra M, Motta F, Harris DR.
Insulin resistance and glucose and lipid concentrations in a cohort of perinatally HIV-infected Latin American children.
Pediatr. Infect. Dis. J. 32: 757-9, 2013.
3)  Sohn AH, Hazra R.
The changing epidemiology of the global paediatric HIV epidemic: keeping track of perinatally HIV-infected adolescents.
J Int AIDS Soc. 16: 18555, 2013.
4)  Hazra R, Cohen RA, Gonin R, Monteiro JP, Hofer CB, Negra MD, Ruz NP.
Lipid levels in the second year of life among HIV-infected and HIV-exposed uninfected Latin American children.
AIDS. 26: 235-40, 2012.
5)  Hazra R, Siberry GK, Mofenson LM.
Growing up with HIV: children, adolescents, and young adults with perinatally acquired HIV infection.
Annu. Rev. Med. 61: 169-85, 2010.
6)  Purdy JB, Gafni RI, Reynolds JC, Zeichner S, Hazra R.
Decreased bone mineral density with off-label use of tenofovir in children and adolescents infected with human immunodeficiency virus.
J. Pediatr. 152: 582-4, 2008.
7)  Harada S, Hazra R, Tamiya S, Zeichner SL, Mitsuya H.
Emergence of human immunodeficiency virus type 1 variants containing the Q151M complex in children receiving long-term antiretroviral chemotherapy.
Antiviral Res. 75: 159-66, 2007.
8)  Schwartz L, Civitello L, Dunn-Pirio A, Ryschkewitsch S, Berry E, Cavert W, Kinzel N, Lawrence DM, Hazra R, Major EO.
Evidence of human immunodeficiency virus type 1 infection of nestin-positive neural progenitors in archival pediatric brain tissue.
J. Neurovirol. 13: 274-83, 2007.
9)  Gafni RI, Hazra R, Reynolds JC, Maldarelli F, Tullio AN, DeCarlo E, Worrell CJ, Flaherty JF, Yale K, Kearney BP, Zeichner SL.
Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy: impact on bone mineral density in HIV-infected children.
Pediatrics. 118: e711-8, 2006.
10)  Feeney ME, Tang Y, Pfafferott K, Roosevelt KA, Draenert R, Trocha A, Yu XG, Verrill C, Allen T, Moore C, Mallal S, Burchett S, McIntosh K, Pelton SI, St John MA, Hazra R, Klenerman P, Altfeld M, Walker BD, Goulder PJ.
HIV-1 viral escape in infancy followed by emergence of a variant-specific CTL response.
J. Immunol. 174: 7524-30, 2005.
Click Here to View Expanded Bibliography.

This page was last updated on 3/10/2014.